Apellis Pharmaceuticals, Inc. (APLS)
26.49
+2.55
(+10.65%)
USD |
NASDAQ |
Jan 07, 16:00
26.52
+0.03
(+0.11%)
After-Hours: 20:00
Apellis Pharmaceuticals Price: 26.49 for Jan. 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 186.91 |
| Amicus Therapeutics, Inc. | 14.30 |
| Fortress Biotech, Inc. | 4.27 |
| Ultragenyx Pharmaceutical, Inc. | 24.20 |
| Fulcrum Therapeutics, Inc. | 9.98 |
Price Related Metrics
| PE Ratio | 89.19 |
| PS Ratio | 3.297 |
| Price to Book Value | 8.355 |
| Price to Free Cash Flow | 42.62 |
| Earnings Yield | 1.12% |
| Market Cap | 3.352B |
| Operating PE Ratio | 41.68 |
| Normalized PE Ratio | 89.19 |